Literature DB >> 7841309

Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis?

E A Shats-Tseytlina1, C H Nair, D P Dhall.   

Abstract

The activation of the complement system has been implicated as an important mechanism in the progression of atherosclerosis. The relationship between fibrin gel characteristics and complement activation has, however, not been investigated. Zymosan-treated plasma with 87% complement activation as measured by C3a production using radioimmunoassay was found to induce changes in biophysical characteristics of fibrin network developed in both plasma and purified fibrinogen solution. Using already established methods to measure fibre thickness (mu T), permeability (T) and compaction, it was found that these networks are made of thinner fibres with increased tensile strength arranged into a matrix which renders the networks less permeable. Such networks are resistant to streptokinase-induced lysis. Fibrin networks with thin fibres in turn induced 3.7 times higher production of C3a than unmodified networks. These observations suggest the existence of positive feedback; complement activation induces major alterations in fibrin structure which in turn can induce further activation of the complement system. The detailed mechanism underlying this interrelationship is not clear at present, but this positive feedback system may play an important role in establishing a fibrin infrastructure ultimately responsible for the progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841309

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Authors:  Vasile I Pavlov; Ying S Tan; Erin E McClure; Laura R La Bonte; Chenhui Zou; William B Gorsuch; Gregory L Stahl
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

2.  Complement C3: an emerging risk factor in cardiometabolic disease.

Authors:  E Hertle; M M J van Greevenbroek; C D A Stehouwer
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

3.  A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

Authors:  K Hess; S H Alzahrani; M Mathai; V Schroeder; A M Carter; G Howell; T Koko; M W J Strachan; J F Price; K A Smith; P J Grant; R A Ajjan
Journal:  Diabetologia       Date:  2011-09-15       Impact factor: 10.122

Review 4.  Complement activation: an emerging player in the pathogenesis of cardiovascular disease.

Authors:  Angela M Carter
Journal:  Scientifica (Cairo)       Date:  2012-12-16

5.  Minor Role of Plasminogen in Complement Activation on Cell Surfaces.

Authors:  Satu Hyvärinen; T Sakari Jokiranta
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.